In vitro activity, safety and in vivo efficacy of the novel bumped kinase inhibitor BKI-1748 in non-pregnant and pregnant mice experimentally infected with Neospora caninum tachyzoites and Toxoplasma gondii oocysts

Aguado-Martínez, 2016, N-terminal fusion of a toll-like receptor 2-ligand to a Neospora caninum chimeric antigen efficiently modifies the properties of the specific immune response, Parasitology, 143, 606, 10.1017/S0031182016000056 Aguado-Martínez, 2017, Neospora caninum in non-pregnant and pregnant mouse models: cross-talk between infection and immunity, Int. J. Parasitol., 47, 723, 10.1016/j.ijpara.2017.09.001 Aguado-Martínez, 2018, Immunization with a cocktail of antigens fused with OprI reduces Neospora caninum vertical transmission and postnatal mortality in mice, Vaccine, 37, 473, 10.1016/j.vaccine.2018.11.060 Anghel, 2020, Comparative assessment of the effects of bumped kinase inhibitors on early zebrafish embryo development and pregnancy in mice, Int. J. Antimicrob. Agents, 56, 10.1016/j.ijantimicag.2020.106099 Arnold, 2017, Necessity of bumped kinase inhibitor gastrointestinal exposure in treating Cryptosporidium infection, J. Infect. Dis., 216, 55, 10.1093/infdis/jix247 Arranz-Solís, 2015, Dose-dependent effects of experimental infection with the virulent Neospora caninum Nc-Spain7 isolate in a pregnant mouse model, Vet. Parasitol., 211, 133, 10.1016/j.vetpar.2015.05.021 Barna, 2013, In vitro effects of novel ruthenium complexes in Neospora caninum and Toxoplasma gondii tachyzoites, Antimicrob. Agents Chemother., 57, 5747, 10.1128/AAC.02446-12 Bishop, 1998, Design of allele-specific inhibitors to probe protein kinase signaling, Curr. Biol., 8, 257, 10.1016/S0960-9822(98)70198-8 Bishop, 1999, Acquisition of inhibitor-sensitive protein kinases through protein design, Pharmacol. Ther., 82, 337, 10.1016/S0163-7258(98)00060-6 Choi, 2020, Bumped Kinase Inhibitors as therapy for apicomplexan parasitic diseases: lessons learned, Int. J. Parasitol., 50, 413, 10.1016/j.ijpara.2020.01.006 Costa, 2000, Real-time PCR for diagnosis and follow-up of Toxoplasma reactivation after allogeneic stem cell transplantation using fluorescence resonance energy transfer hybridization probes, J. Clin. Microbiol., 38, 2929, 10.1128/JCM.38.8.2929-2932.2000 Debache, 2008, Vaccination of mice with recombinant NcROP2 antigen reduces mortality and cerebral infection in mice infected with Neospora caninum tachyzoites, Int. J. Parasitol., 38, 1455, 10.1016/j.ijpara.2008.04.001 Debache, 2009, Vaccination with recombinant NcROP2 combined with recombinant NcMIC1 and NcMIC3 reduces cerebral infection and vertical transmission in mice experimentally infected with Neospora caninum tachyzoites, Int. J. Parasitol., 39, 1373, 10.1016/j.ijpara.2009.04.006 Dubey, 2017 Hampton, 2015, Congenital toxoplasmosis: a review, Neonatal Netw, 34, 274, 10.1891/0730-0832.34.5.274 Huang, 2019, Development of 5-Aminopyrazole-4-carboxamide-based bumped-kinase inhibitors for Cryptosporidiosis therapy, J. Med. Chem., 62, 3135, 10.1021/acs.jmedchem.9b00069 Hulverson, 2019, Pharmacokinetics and in vivo efficacy of pyrazolopyrimidine , pyrrolopyrimidine , and 5-aminopyrazole-4-carboxamide bumped kinase inhibitors against toxoplasmosis, J. Infect. Dis., 219, 1464, 10.1093/infdis/jiy664 Jiménez-Meléndez, 2017, In vitro efficacy of bumped kinase inhibitors against Besnoitia besnoiti tachyzoites, Int. J. Parasitol., 47, 811, 10.1016/j.ijpara.2017.08.005 Keyloun, 2014, The gatekeeper residue and beyond: homologous calcium-dependent protein kinases as drug development targets for veterinarian Apicomplexa parasites, Parasitology, 141, 1499, 10.1017/S0031182014000857 Kieschnick, 2001, Toxoplasma gondii attachment to host cells is regulated by a calmodulin-like domain protein kinase, J. Biol. Chem., 276, 12369, 10.1074/jbc.M011045200 Murphy, 2010, Discovery of potent and selective inhibitors of CDPK1 from C. parvum and T. gondii, ACS Med. Chem. Lett., 1, 331, 10.1021/ml100096t Müller, 2017, Development of a murine vertical transmission model for Toxoplasma gondii oocyst infection and studies on the efficacy of bumped kinase inhibitor (BKI)-1294 and the naphthoquinone buparvaquone against congenital toxoplasmosis, J. Antimicrob. Chemother., 72, 2334, 10.1093/jac/dkx134 Müller, 2017, Two novel calcium-dependent protein kinase 1 inhibitors interfere with vertical transmission in mice infected with Neospora caninum tachyzoites, Antimicrob. Agents Chemother., 61, 16, 10.1128/AAC.02324-16 Müller, 2002, Application of real-time fluorescent PCR for quantitative assessment of Neospora caninum infections in organotypic slice cultures of rat central nervous system tissue, J. Clin. Microbiol., 40, 252, 10.1128/JCM.40.1.252-255.2002 Nagamune, 2008, Calcium regulation and signaling in apicomplexan parasites BT - molecular mechanisms of parasite invasion: subcellular Biochemistry Ojo, 2010, Toxoplasma gondii calcium-dependent protein kinase 1 is a target for selective kinase inhibitors, Nat. Struct. Mol. Biol., 17, 602, 10.1038/nsmb.1818 Ojo, 2014, Neospora caninum calcium-dependent protein kinase 1 is an effective drug target for neosporosis therapy, PloS One, 9, 275, 10.1371/journal.pone.0092929 Ojo, 2017, Selective inhibition of Sarcocystis neurona calcium-dependent protein kinase 1 for equine protozoal myeloencephalitis therapy, Int. J. Parasitol., 46, 871, 10.1016/j.ijpara.2016.08.003 Sánchez-Sánchez, 2018, Safety and efficacy of the bumped kinase inhibitor BKI-1553 in pregnant sheep experimentally infected with Neospora caninum tachyzoites, Int. J. Parasitol. Drugs Drug Resist., 8, 112, 10.1016/j.ijpddr.2018.02.003 Sánchez-Sánchez, 2018, Treatment of toxoplasmosis and neosporosis in farm ruminants: state of knowledge and future trends, Curr. Top. Med. Chem., 1304, 10.2174/1568026618666181002113617 Sánchez-Sánchez, 2019, Treatment with bumped kinase inhibitor 1294 is safe and leads to significant protection against abortion and vertical transmission in sheep experimentally infected with Toxoplasma gondii during pregnancy, Antimicrob. Agents Chemother., 63, 1, 10.1128/AAC.02527-18 Sánchez-Sánchez, 2019, Virulence in mice of a Toxoplasma gondii type II isolate does not Correlate with the outcome of experimental infection in pregnant sheep, Front. Cell. Infect. Microbiol., 9, 1 Smith, 2021, Control of human toxoplasmosis, Int. J. Parasitol., 51, 95, 10.1016/j.ijpara.2020.11.001 Webster, 2010, J.P. Toxoplasmosis of Animals and Humans, Parasit. Vectors, 3, 112, 10.1186/1756-3305-3-112 Wernimont, 2010, Structures of apicomplexan calcium-dependent protein kinases reveal mechanism of activation by calcium, Nat. Struct. Mol. Biol., 17, 596, 10.1038/nsmb.1795 Winzer, 2015, In vitro and in vivo effects of the bumped kinase inhibitor 1294 in the related cyst-forming apicomplexans Toxoplasma gondii and Neospora caninum, Antimicrob. Agents Chemother., 59, 6361, 10.1128/AAC.01236-15 Winzer, 2020, The impact of BKI-1294 therapy in mice infected with the apicomplexan parasite Neospora caninum and Re-infected during pregnancy, Front. Vet. Sci., 7, 1, 10.3389/fvets.2020.587570 Winzer, 2020, Neospora caninum: structure and fate of multinucleated complexes induced by the bumped kinase inhibitor bki-1294, Pathogens, 9, 1, 10.3390/pathogens9050382 Winzer, 2020, Neospora caninum: differential proteome of multinucleated complexes induced by the bumped kinase inhibitor BKI-1294, Microorganisms, 8, 1, 10.3390/microorganisms8060801